Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      IMAX Corporation Reports First Quarter 2021 Results

      HIGHLIGHTS

      - IMAX continues to help lead the global film industry out of the pandemic as pent-up demand emerges in global markets driving year-over-year quarterly growth in revenue, box office, gross margins and EBITDA

      - Company posts $110 million in global box office -- its first year-over-year quarterly box office growth of the pandemic period -- as strong rebound in Asia continues and begins to expand to other key markets

      - IMAX expects further market openings and loosening of capacity restrictions to drive increased network capacity as summer tentpoles including "A Quiet Place 2," "Fast 9," and "Black Widow" arrive in theaters

      - Company raised $230 million in gross proceeds through successful convertible notes offering, further strengthening its financial position and reducing annualized cash interest by approximately $4.3 million or 55%

      - IMAX continues to innovate with announcement of new joint-venture to explore the application of artificial intelligence for super resolution image enhancement across consumer devices and streaming platforms

      IMAX Logo. (PRNewsFoto/IMAX Corporation)

      News provided by

      IMAX Corporation

      Apr 29, 2021, 08:05 ET

      Share this article

      Share this article


      NEW YORK, April 29, 2021 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX) today reported financial results for the first quarter 2021 including year-over-year revenue and box office growth, margin improvement and positive EBITDA — demonstrating strong demand for The IMAX Experience® as theaters reopen around the world.  

      "The last year has brought the strong, unique market position of IMAX into sharp focus; we are a global platform for blockbuster entertainment with a valuable brand, flexible, asset-lite business model and strong balance sheet," said Richard L. Gelfond, CEO of IMAX Corporation. "The distinct attributes of our business and brand enable IMAX to help lead the global film industry out of the pandemic — drawing audiences back to the theaters and driving revenue across the ecosystem, as IMAX continues to grow its global footprint, box office, and market share."

      "Through our unique global footprint, we continue to see firsthand that where audiences feel safe and the virus is under control they will return quickly to the theaters. Audiences across Asia continue to rediscover the theatrical experience in impressive numbers, driving record-breaking box office and accelerating the continued shift to blockbusters at the multiplex. As Hollywood tentpoles return to theaters, the recovery is spreading to North America and key additional markets including Russia, and Saudi Arabia with the summer season ahead."

      "As the pandemic recedes, we see clear evidence of global consumers, who've been stuck at home with limited entertainment options, emerging to seek out experiences that transcend the ordinary. The IMAX Experience® is at once accessible and affordable yet immersive and transporting. With cinema among the most significant out-of-home entertainment experiences to come back online, we believe IMAX is well-positioned to capitalize on this movement."

      "IMAX remains very confident in its leadership position in out-of-home entertainment and continues to explore ways to capitalize on the strength of its brand and technology for the in-home and streaming market as well. Our IMAX Enhanced initiative now encompasses more than 25 device manufacturer and streaming partners across Asia, Europe, and North America, and we recently announced a joint-venture with a cutting-edge artificial intelligence firm to explore solutions for high-speed image enhancement across consumer devices and streaming platforms."

      IMAX delivered global box office of $110 million for the quarter, marking the Company's first year-over-year quarterly box office growth since the pandemic began. Results were driven by the strong rebound of moviegoing in Asia and encouraging performances at the multiplex as other global markets reopen. For the quarter, IMAX achieved record-breaking Chinese New Year opening weekend results; its number-one and number-two highest grossing Japanese local language releases of all time; and its strongest North American opening of the pandemic period with "Godzilla vs. Kong," which also performed well in key markets including Mexico, Russia, Spain, and Saudi Arabia.

      IMAX reported first quarter 2021 revenues of $38.8 million, gross margin of $17.3 million, and a net loss attributable to common shareholders of ($14.8) million, or ($0.25) per diluted share. IMAX achieved positive EBITDA per Credit Facility(1) and its first quarter of year-over-year EBITDA growth since the onset of the pandemic. In the first quarter 2021, the Company continued to strengthen its balance sheet, amending its credit facility and raising $230 million of convertible notes. As a result of the transactions, IMAX added more than $200 million in total available liquidity and reduced its pro forma annual cash interest costs by $4.3 million.

      IMAX first quarter 2021 net loss attributable to common shareholders reflects the impact of COVID-19 on the Company's network, including theater closures and capacity restrictions, in addition to a non-cash valuation allowance to reduce the value of deferred tax assets of $7.0 million or $0.12 per share. However, the Company also benefited from a $5.2 million gain on the sale of its investment in Maoyan Entertainment ($3.7 million attributable to common shareholders) and $1.5 million of COVID-19 government relief benefits.

      Additionally, IMAX today announced that Patrick McClymont, Chief Financial Officer of IMAX, will be leaving the Company to become Chief Financial Officer of a private company. McClymont, who has served in the role since 2016, will step down next month. Joseph Sparacio, who preceded McClymont as Chief Financial Officer of IMAX and more recently served as Chief Financial Officer of Entertainment One, will temporarily rejoin the Company to serve as Interim Chief Financial Officer of IMAX while a search is conducted to fill the role permanently.

      "On behalf of IMAX, I want to thank Patrick for his significant and valued contributions to the Company throughout his tenure," said Gelfond. "He is a strategic, thoughtful executive and we wish him and his family all the best of luck in their new adventure. IMAX is in a strong financial position with real momentum as we grow our network and brand throughout the world and I am confident that momentum will continue without interruption as we search for a successor."

      First Quarter Financial Highlights



      Three Months Ended




      March 31,


      In millions of U.S. Dollars, except per share data


      2021



      2020



      YoY %

      Change


      Total Revenue


      $

      38.8



      $

      34.9




      11.0

      %














      Gross Margin


      $

      17.3



      $

      5.1




      239.8

      %

      Gross Margin (%)



      44.6

      %



      14.6

      %


















      Net Loss attributable to common shareholders


      $

      (14.8)



      $

      (49.4)




      69.9

      %

      Diluted Net Loss per share attributable to common shareholders


      $

      (0.25)



      $

      (0.82)




      69.5

      %

      Adjusted Net Loss attributable to common shareholders(1)


      $

      (14.8)



      $

      (28.7)




      48.4

      %

      Adjusted Net Loss per share attributable to common shareholders(1)


      $

      (0.25)



      $

      (0.48)




      47.9

      %














      Adjusted EBITDA per Credit Facility attributable to common
      shareholders(1)


      $

      2.8



      $

      (4.4)




      163.9

      %

      Adjusted EBITDA Margin attributable to common shareholders
      (%) (1)



      9.0

      %



      (13.1)

      %



      168.5

      %

      ____________

      (1)     Non-GAAP Financial Measure


      Note: For the definition and reconciliations of reported results to non-GAAP financial results, please refer to the discussion of non-GAAP financial measures at the end of this earnings release.

      First Quarter Segment Results(1)

      In millions of U.S. Dollars


      IMAX Technology

      Network



      IMAX Technology Sales and
      Maintenance






























      Revenue



      Gross
      Margin

      Gross
      Margin %



      Revenue



      Gross
      Margin



      Gross
      Margin %


      1Q21


      $

      20.3



      $

      10.1




      49.9

      %


      $

      17.0




      $

      7.1




      41.5

      %

      1Q20


      16.6




      2.8




      17.0

      %


      15.1





      4.7




      31.3

      %

      % change



      22.3

      %



      258.7

      %







      12.5

      %




      49.3

      %





      _____________

      (1)     Please refer to the Company's Form 10-Q for the period ended March 31, 2021 for additional segment information

      IMAX Technology Network

      • IMAX Technology Network revenues increased 22.3% to $20.3 million in the first quarter of 2021, compared to $16.6 million in the prior-year period. The continued reopening of the Company's network, particularly in Asia, and strong performance of local-language content during the Chinese New Year holiday period, drove the increase in gross box office and revenue.
      • Gross margin for the IMAX Technology Network of $10.1 million in the first quarter of 2021 increased by more than $7 million as improved box office performance drove higher revenue.

       IMAX Technology Sales and Maintenance

      • IMAX Technology Sales and Maintenance revenues increased 12.5% to $17.0 million in the first quarter of 2021, compared with $15.1 million in the prior year period. The increase in revenue was the result of higher IMAX Maintenance sales associated with the continued reopening of our global network
      • Total gross margin for IMAX Technology Sales and Maintenance increased 49.3% to $7.1 million compared to $4.7 million in the prior year period. The increase in gross margin was the result of higher IMAX Maintenance driven revenue and modest cost reductions.

      Cash Balances and Outstanding Debt

      Total cash and cash equivalents as of March 31, 2021 were $267.8 million. Total debt, excluding deferred financing fees, was $283 million as of March 31, 2021.

      Share Count and Capital Return

      The weighted average basic and diluted shares outstanding at the end of the first quarter of 2021 declined 2.3% to 59.0 million, compared to 60.4 million in the first quarter of 2020, due primarily to share repurchase activity early in 2020. During the first quarter of 2021, the Company did not repurchase any stock. A total of $89.4 million remains available under the Company's outstanding share repurchase authorization, which was extended an additional year through to June 2022.

      Supplemental Materials

      For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.

      Investor Relations Website and Social Media

      On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag.

      The Company may post additional information on the Company's corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases, SEC filings and public conference calls and webcasts, for additional information about the Company

      Conference Call

      The Company will host a conference call today at 8:30AM ET to discuss its first quarter 2021 financial results. This call is being webcast by PGI and can be accessed at investors.imax.com. To access the call via telephone, interested parties in the US and Canada should dial (800) 367-2403 approximately 5 to 10 minutes before the call begins. Other international callers should dial (647) 490-5367. The conference ID for the call is 2982656. A replay of the call will be available via webcast at investors.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 2982656.

      About IMAX Corporation

      IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.

      IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of March 31, 2021, there were 1,652 IMAX theater systems (1,567 commercial multiplexes, 12 commercial destinations, 73 institutional) operating in 84 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code "1970."

      IMAX®, IMAX® Dome, IMAX® 3D, IMAX® 3D Dome, Experience It In IMAX®, The IMAX Experience®, An IMAX Experience®, An IMAX 3D Experience®, IMAX DMR®, DMR®, IMAX nXos® and Films to the Fullest®, are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Instagram (https://www.instagram.com/imax), Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

      For additional information please contact:

      Investors:
      IMAX Corporation, New York
      Brett Harriss
      212-821-0187
      [email protected]

      Media:
      IMAX Corporation, New York
      Mark Jafar
      212-821-0102
      [email protected]

      Forward-Looking Statements

      This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, references to business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior,  plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, the impact of COVID-19 on the Company's business, financial conditions and results of operations and on the businesses of our customers and exhibitor partners; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company's growth and operations in China; the performance of IMAX DMR® films; the signing of IMAX Theater System agreements; conditions, changes and developments in the commercial exhibition industry and broader entertainment industry, including both the in-home and out-of-home entertainment markets; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in entertainment technology; risks relating to consolidation among commercial exhibitors and movie studios; risks related to new business initiatives that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company's inability to protect the Company's intellectual property; risks related to the Company's indebtedness and compliance with its debt agreements; general economic, market or business conditions; the failure to convert IMAX Theater System backlog into revenue; changes in laws or regulations; the failure to fully realize the projected cost savings and benefits from any of the Company's restructuring initiatives; assumptions related to the foregoing; other risks outlined in our periodic filings with the SEC; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

      Primary Reporting Groups

      The Company has the following reportable segments: (i) IMAX DMR; (ii) Joint Revenue Sharing Arrangements; (iii) IMAX Systems, (iv) IMAX Maintenance; (v) Other Theater Business; (vi) New Business Initiatives; (vii) Film Distribution; and (viii) Film Post-Production. The Company organizes its reportable segments into the following four categories, identified by the nature of the product sold or service provided:

      (i)

      IMAX Technology Network, which earns revenue based on contingent box office receipts and includes the IMAX DMR segment and contingent rent from the Joint Revenue Sharing Arrangement ("JRSA") segment;



      (ii)

      IMAX Technology Sales and Maintenance, which includes results from the IMAX Systems, IMAX Maintenance and Other Theater Business segments, as well as fixed revenues from the JRSA segment;



      (iii)

      New Business Initiatives, which is a segment that includes activities related to the exploration of new lines of business and new initiatives outside of the Company's core business; and



      (iv)

      Film Distribution and Post-Production, which includes activities related to the licensing of film content, the distribution of films primarily for the Company's institutional theater partners (through the Film Distribution segment) and the provision of film post-production and quality control services (through the Film Post-Production segment).

      IMAX Network and Backlog



      Three Months

      Ended March 31,



      Theater System Signings:


      2021




      2020



      New IMAX Theater Systems











      Sales and sales-type lease arrangements



      6





      2



      Hybrid joint revenue sharing arrangements



      —





      —



      Traditional joint revenue sharing arrangements



      —





      2



         Total new IMAX theaters Systems



      6





      4



      Upgrades of IMAX theater systems



      —





      11



         Total IMAX Theater System signings



      6





      15
















      Three Months

      Ended March 31,



      Theater System Installations:


      2021




      2020



      New IMAX Theater Systems











      Sales and sales-type lease arrangements



      2





      2



      Hybrid joint revenue sharing lease arrangements



      2





      1



      Traditional joint revenue sharing arrangements



      5





      2



         Total new IMAX Theater Systems



      9





      5



      Upgrades of IMAX theater systems



      3





      7



         Total IMAX Theater System installations



      12





      12
















      Three Months

      Ended March 31,



      Theater Sales Backlog:


      2021




      2020



      Sales and sales-type lease arrangements



      189





      180



      Hybrid joint revenue sharing arrangements



      144





      138



      Traditional joint revenue sharing arrangements



      188

      (1)




      215

      (1)


      Total Theater backlog



      521

      (2)




      533

      (3)















      Three Months

      Ended March 31,



      Theater Network:


      2021




      2020



      Commercial Multiplex Theaters











      Sales and sales-type lease arrangements



      671





      659



      Hybrid joint revenue sharing lease arrangements



      143





      136



      Traditional joint revenue sharing lease arrangements



      753





      731



      Total Commercial Multiplex Theaters



      1,567





      1,526



      Commercial Destination Theaters



      12





      14



      Institutional Theaters



      73





      76



      Total Theater network(4)



      1,652





      1,616



      _____________

      (1)

      Includes 44 IMAX Theater Systems where the customer has the option to convert from a joint revenue sharing arrangement to a sales arrangement (2020 — 46).

      (2)

      Includes 149 new IMAX with Laser projection system configurations and 92 upgrades of existing locations to IMAX with Laser projection system configurations.

      (3)

      Includes 147 new IMAX with Laser projection system configurations and 94 upgrades of existing locations to IMAX with Laser projection system configurations.

      (4)

      Period-to-period changes are reported net of the effect of permanently closed theaters.


      IMAX CORPORATION

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

      (In thousands of U.S. dollars, except per share amounts)

      (Unaudited)





      Three Months Ended





      March 31,





      2021



      2020


      Revenues









      Technology sales


      $

      6,175



      $

      5,662


      Image enhancement and maintenance services



      21,615




      20,721


      Technology rentals



      8,359




      5,971


      Finance income



      2,605




      2,548






      38,754




      34,902


      Costs and expenses applicable to revenues









      Technology sales



      5,053




      3,869


      Image enhancement and maintenance services



      9,764




      17,816


      Technology rentals



      6,656




      8,131






      21,473




      29,816


      Gross margin



      17,281




      5,086


      Selling, general and administrative expenses



      25,209




      28,636


      Research and development



      1,471




      2,200


      Amortization of intangibles



      1,141




      1,321


      Credit loss expense



      305




      10,217


      Asset impairments



      —




      1,151


      Loss from operations



      (10,845)




      (38,439)


      Realized and unrealized investment gains (losses)



      5,248




      (4,539)


      Retirement benefits non-service expense



      (114)




      (116)


      Interest income



      583




      365


      Interest expense



      (2,304)




      (648)


      Loss before taxes



      (7,432)




      (43,377)


      Income tax expense



      (3,068)




      (15,505)


      Equity in losses of investees, net of tax


      —




      (529)


      Net Loss



      (10,500)




      (59,411)


      Less: Net (income) loss attributable to non-controlling interests



      (4,340)




      10,057


      Net loss attributable to common shareholders


      $

      (14,840)



      $

      (49,354)


      Net loss per share attributable to common shareholders -

            basic and diluted:






      Net loss per share — basic and diluted


      $

      (0.25)



      $

      (0.82)












      Weighted average number of shares outstanding (000's):










      Basic



      59,012




      60,418



      Fully Diluted



      59,012




      60,418


      Additional Disclosure:









      Depreciation and amortization(1)


      $

      12,986



      $

      15,252


      _____________

      (1)

      Includes $0.3 million of amortization of deferred financing costs charged to interest expense for the three months March 31, 2021 (2020 — $0.1 million).

      IMAX CORPORATION

      CONDENSED CONSOLIDATED BALANCE SHEETS

      (In thousands of dollars, except share amounts)

      (Unaudited)





      March 31,



      December 31,




      2021



      2020


      Assets









      Cash and cash equivalents


      $

      267,794



      $

      317,379


      Accounts receivable, net



      69,582




      56,300


      Financing receivables, net



      130,836




      131,810


      Variable consideration receivables, net



      41,095




      40,526


      Inventories



      39,119




      39,580


      Prepaid expenses



      12,762




      10,420


      Film assets, net



      5,793




      5,777


      Property, plant and equipment, net



      269,820




      277,397


      Investment in equity securities



      1,086




      13,633


      Other assets



      21,799




      21,673


      Deferred income tax assets, net



      18,303




      17,983


      Goodwill



      39,027




      39,027


      Other intangible assets, net



      25,347




      26,245


      Total assets


      $

      942,363



      $

      997,750


      Liabilities









      Accounts payable


      $

      16,224



      $

      20,837


      Accrued and other liabilities



      104,499




      99,354


      Revolving credit facility borrowings, net



      50,813




      305,676


      Convertible notes, net



      222,486




      —


      Deferred revenue



      93,208




      87,982


      Deferred income tax liabilities



      19,681




      19,134


      Total liabilities



      506,911




      532,983


      Commitments and contingencies









      Non-controlling interests



      750




      759


      Shareholders' equity









      Capital stock common shares — no par value. Authorized — unlimited number.









      59,358,679 issued and 59,357,956 outstanding (December 31, 2020 — 58,921,731 issued and 58,921,008 outstanding)



      414,993




      407,031


      Less: Treasury stock, 723 shares at cost (December 31, 2020 — 723)



      (11)




      (11)


      Other equity



      155,653




      180,330


      Accumulated deficit



      (217,689)




      (202,849)


      Accumulated other comprehensive (loss) income



      (459)




      988


      Total shareholders' equity attributable to common shareholders



      352,487




      385,489


      Non-controlling interests



      82,215




      78,519


      Total shareholders' equity



      434,702




      464,008


      Total liabilities and shareholders' equity


      $

      942,363



      $

      997,750


      IMAX CORPORATION

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      (In thousands of dollars)

      (Unaudited)




      Three Months Ended




      March 31,





      2021




      2020


      Operating Activities









      Net loss


      $

      (10,500)



      $

      (59,411)


      Adjustments to reconcile net loss to cash (used in) provided by operating activities:









      Depreciation and amortization



      12,986




      15,252


      Credit loss expense



      305




      10,217


      Write-downs



      213




      4,403


      Deferred income tax expense



      158




      5,627


      Share-based and other non-cash compensation



      5,421




      4,309


      Unrealized foreign currency exchange loss



      113




      223


      Realized and unrealized investment (gains) losses



      (5,248)




      4,539


      Equity in losses of investees



      —




      529


      Changes in assets and liabilities:









      Accounts receivable



      (13,744)




      28,191


      Inventories



      437




      (18,344)


      Film assets



      (2,213)




      (3,064)


      Deferred revenue



      5,276




      8,807


      Changes in other operating assets and liabilities



      (4,155)




      4,688


      Net cash (used in) provided by operating activities



      (10,951)




      5,966


      Investing Activities









      Purchase of property, plant and equipment



      (466)




      (271)


      Investment in equipment for joint revenue sharing arrangements



      (1,540)




      (1,580)


      Acquisition of other intangible assets



      (1,507)




      (862)


      Proceeds from sale of equity securities



      17,769




      —


      Net cash provided by (used in) investing activities



      14,256




      (2,713)


      Financing Activities









      Proceeds from issuance of convertible notes, net



      223,675




      —


      Purchase of capped calls related to convertible notes



      (19,067)




      —


      Revolving credit facility borrowings



      —




      280,000


      Repayments of revolving credit facility borrowings



      (255,000)




      —


      Credit facility amendment fees paid



      (32)




      —


      Settlement of restricted share units and options



      —




      (1,667)


      Treasury stock repurchased for future settlement of restricted share units



      —




      (1,419)


      Repurchase of common shares, IMAX China



      —




      (891)


      Taxes withheld and paid on employee stock awards vested



      (3,045)




      (236)


      Common shares issued - stock options exercised



      824




      —


      Repurchase of common shares



      —




      (36,624)


      Net cash (used in) provided by financing activities



      (52,645)




      239,163


      Effects of exchange rate changes on cash



      (245)




      377


      (Decrease) increase in cash and cash equivalents during period



      (49,585)




      242,793


      Cash and cash equivalents, beginning of period



      317,379




      109,484


      Cash and cash equivalents, end of period


      $

      267,794



      $

      352,277






      Three Months Ended




      March 31,




      2021



      2020


      Revenue









      IMAX Technology Network









      IMAX DMR


      $

      11,944



      $

      10,629


      Joint revenue sharing arrangements, contingent rent



      8,359




      5,971





      20,303




      16,600


      IMAX Technology Sales and Maintenance









      IMAX Systems



      5,899




      5,688


      Joint revenue sharing arrangements, fixed fees



      1,738




      770


      IMAX Maintenance



      8,906




      7,370


      Other Theater Business



      437




      1,263





      16,980




      15,091


      New Business Initiatives



      668




      478


      Film Distribution and Post-production



      813




      2,494





      38,764




      34,663


      Other



      (10)




      239


      Total revenues


      $

      38,754



      $

      34,902











      Gross Margin (Margin Loss)









      IMAX Technology Network









      IMAX DMR(1)


      $

      8,251



      $

      4,443


      Joint revenue sharing arrangements, contingent rent(1)



      1,883




      (1,618)





      10,134




      2,825


      IMAX Technology Sales and Maintenance









      IMAX Systems (1)



      3,012




      3,176


      Joint revenue sharing arrangements, fixed fees(1)



      156




      179


      IMAX Maintenance



      3,823




      759


      Other Theater Business



      63




      610





      7,054




      4,724


      New Business Initiatives



      458




      361


      Film Distribution and Post-production (1)(2)



      (25)




      (1,935)





      17,621




      5,975


      Other



      (340)




      (889)


      Total Segment Margin


      $

      17,281



      $

      5,086


      _____________

      (1)

      IMAX DMR gross margin includes marketing costs of $1.1 million for the three months ended March 31, 2021 (2020 — $2.4 million). JRSA gross margin includes advertising, marketing and commission expense of $0.8 million for the three months March 31, 2021 (2020 —$0.5 million). IMAX Systems gross margin includes marketing and commission costs of $0.2 million for the three months ended March 31, 2021 (2020 — $0.2 million). Film Distribution segment gross margin includes marketing recovery of less than $0.1 million for the three months ended March 31, 2021, (2020 — expense of $0.2 million).



      (2)

      During the three months ended March 31, 2020, Film Distribution segment results include impairment losses of $2.3 million to write-down the carrying value of certain documentary and alternative content film assets due to a decrease in projected box office totals and related revenues based on management's regular quarterly recoverability assessments. No such charges incurred in the three months ended March 31, 2021.

      IMAX CORPORATION
      NON-GAAP FINANCIAL MEASURES
      (in thousands of U.S. dollars)

      In this release, the Company presents adjusted net loss attributable to common shareholders and adjusted net loss attributable to common shareholders per diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin, and free cash flow as supplemental measures of the Company's performance, which are not recognized under U.S. GAAP. Adjusted net loss attributable to common shareholders and adjusted net loss attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) COVID-19 government relief benefits, (iii) realized and unrealized investment (gains) losses, as well as the related tax impact of these adjustments, and (iv) income taxes resulting from management's decision to no longer indefinitely reinvest the historical earnings of certain foreign subsidiaries.

      The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net loss attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

      A reconciliation from net loss attributable to common shareholders and the associated per share amounts to adjusted net loss attributable to common shareholders and adjusted net loss attributable to common shareholders per diluted share is presented in the table below. Net loss attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.

      In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as such term is defined in the Company's Credit Agreement, and which is referred to herein as "Adjusted EBITDA per Credit Facility." As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Adjusted EBITDA per Credit Facility measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its Credit Agreement requirements when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.

      EBITDA is defined as net income or loss excluding (i) interest expense, net of interest income; (ii) income tax expense or benefit; and (iii) depreciation and amortization, including film asset amortization. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment (gains) losses; (iii) write-downs, net of recoveries, including asset impairments and credit loss expense; (iv) legal judgment and arbitration awards; and (v) gain or loss from equity accounted investments.

      A reconciliation of net loss attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net loss attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company's shareholders, rather than the earnings attributable to non-controlling interests.

      Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the Condensed Consolidated Statements of Cash Flows). Cash provided by operating activities consist of net (loss) income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

      These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.

      Adjusted EBITDA per Credit Facility




      For the Three Months Ended March 31, 2021 (1)



      For the Three Months Ended March 31, 2020 (1)




      Attributable to

      Non-controlling



      Less:






      Attributable to

      Non-controlling



      Less:







      Interests and



      Attributable to



      Attributable to



      Interests and



      Attributable to



      Attributable to




      Common



      Non-controlling



      Common



      Common



      Non-controlling



      Common




      Shareholders



      Interests



      Shareholders



      Shareholders



      Interests



      Shareholders


      (In thousands of U.S. Dollars)































      Reported net loss


      $


      (10,500)



      $


      4,340



      $


      (14,840)



      $


      (59,411)



      $


      (10,057)



      $


      (49,354)


      Add (subtract):































      Income tax expense




      3,068





      974





      2,094





      15,505





      4,556





      10,949


      Interest expense, net of interest income




      1,412





      (86)





      1,498





      150





      (103)





      253


      Depreciation and amortization, including film asset 
           
      amortization




      12,986





      1,149





      11,837





      15,252





      1,240





      14,012


      EBITDA


      $


      6,966



      $


      6,377



      $


      589



      $


      (28,504)



      $


      (4,364)



      $


      (24,140)


      Share-based and other non-cash compensation




      5,421





      246





      5,175





      4,309





      151





      4,158


      Realized and unrealized investment (gains) losses




      (5,248)





      (1,571)





      (3,677)





      4,539





      1,374





      3,165


      Write-downs, including asset

      impairments and credit loss expense




      518





      (180)





      698





      14,620





      2,692





      11,928


      Loss from equity accounted investments




      —





      —





      —





      529





      —





      529


      Adjusted EBITDA per Credit Facility


      $


      7,657



      $


      4,872



      $


      2,785



      $


      (4,507)



      $


      (147)



      $


      (4,360)


      Revenues attributable to common

         shareholders(2)




      38,754





      7,699





      31,055





      34,902





      1,596





      33,306


      Adjusted EBITDA margin attributable to common

         shareholders




      19.8

      %




      63.3

      %




      9.0

      %




      -12.9

      %




      -9.2

      %




      -13.1

      %


































      For the Twelve Months Ended March 31, 2021 (1)



      For the Twelve Months Ended March 31, 2020 (1)




      Attributable to

      Non-controlling



      Less:






      Attributable to

      Non-controlling



      Less:







      Interests and



      Attributable to



      Attributable to



      Interests and



      Attributable to



      Attributable to




      Common



      Non-controlling



      Common



      Common



      Non-controlling



      Common




      Shareholders



      Interests



      Shareholders



      Shareholders



      Interests



      Shareholders


      (In thousands of U.S. Dollars)































      Reported net loss


      $


      (108,575)



      $


      686



      $


      (109,261)



      $


      (13,327)



      $


      (2,574)



      $


      (10,753)


      Add (subtract):































      Income tax expense




      14,067





      1,826





      12,241





      28,624





      7,255





      21,369


      Interest expense, net of interest income




      4,982





      (353)





      5,335





      462





      (468)





      930


      Depreciation and amortization, including film asset 
           
      amortization




      51,340





      4,479





      46,861





      64,527





      5,025





      59,502


      EBITDA


      $


      (38,186)



      $


      6,638



      $


      (44,824)



      $


      80,286



      $


      9,238



      $


      71,048


      Share-based and other non-cash compensation




      23,150





      1,063





      22,087





      23,356





      659





      22,697


      Realized and unrealized investment (gains) losses




      (7,706)





      (2,314)





      (5,392)





      7,549





      2,331





      5,218


      Write-downs, including asset impairments and

         credit loss expense




      22,235





      5,492





      16,743





      20,729





      3,689





      17,040


      Legal judgment and arbitration awards




      4,105





      —





      4,105





      —





      —





      —


      Loss from equity accounted investments




      1,329





      —





      1,329





      442





      —





      442


      Adjusted EBITDA per Credit Facility


      $


      4,927



      $


      10,879



      $


      (5,952)



      $


      132,362



      $


      15,917



      $


      116,445


      Revenues attributable to common

         shareholders(2)




      140,855





      21,870





      118,985





      350,368





      31,132





      319,236


      Adjusted EBITDA margin attributable to common

         shareholders




      3.5

      %




      49.7

      %




      -5.0

      %




      37.8

      %




      51.1

      %




      36.5

      %

      _____________

      (1)     The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis. During the first quarter of 2021, the Company entered into the Second Amendment to the Credit Facility Agreement which, among other things, suspends the Senior Secured Net Leverage Ratio financial covenant in the Credit Agreement through the first quarter of 2022 and, once re-established, permits the Company to use EBITDA from the third and fourth quarters of 2019 in lieu of EBITDA for the corresponding quarters of 2021.

      (2)



      Three months ended
      March 31, 2021


      Three months ended
      March 31, 2020


      12 months ended
      March 31, 2021


      12 months ended
      March 31, 2020


      Total revenues







      $


      38,754







      $


      34,902







      $


      140,855






      $


      350,368


      Greater China revenues


      $


      25,518







      $


      5,269







      $


      72,580







      $


      102,882






      Non-controlling interest ownership percentage(3)




      30.17

      %








      30.29

      %








      30.13

      %








      30.26

      %





      Deduction for non-controlling interest share of revenues









      (7,699)









      (1,596)









      (21,870)








      (31,132)


      Revenues attributable to common shareholders







      $


      31,055







      $


      33,306







      $


      118,985






      $


      319,236



      (3)     Weighted average ownership percentage for change in non-controlling interest share


      Adjusted Net Loss Attributable to Common Shareholders and Adjusted Diluted Per Share Calculations




      Three Months Ended




      Three Months Ended




      March 31, 2021




      March 31, 2020


      (In thousands of U.S. Dollars, except per share amounts)


      Net Loss




      Per Share




      Net Loss




      Per Share


      Reported net loss attributable to common shareholders


      $

      (14,840)




      $

      (0.25)




      $

      (49,354)




      $

      (0.82)


      Adjustments(1):




















      Share-based compensation



      5,348





      0.09





      4,075





      0.07


      COVID-19 government relief benefits(2)



      (1,484)





      (0.03)





      —





      —


      Realized and unrealized investment (gains) losses



      (3,677)





      (0.06)





      3,165





      0.05


      Tax impact on items listed above



      (537)





      (0.01)





      (338)





      (0.01)


      Income taxes resulting from management's decision to no longer indefinitely reinvest the historical earnings of certain foreign subsidiaries



      381





      0.01





      13,726





      0.23


      Adjusted net loss(1)


      $

      (14,809)




      $

      (0.25)




      $

      (28,726)




      $

      (0.48)






















      Weighted average basic shares outstanding








      59,012










      60,418


      Weighted average diluted shares outstanding








      59,012










      60,418


      _____________

      (1)

      Reflects amounts attributable to common shareholders.

      (2)

      In the three months ended March 31, 2021, the Company recognized $1.5 million in benefits from the CEWS program, as reductions to Selling, General and Administrative Expenses ($1.2 million) and Costs and Expenses Applicable to Revenues ($0.3 million) in the Condensed Consolidated Statements of Operations. No such benefits were recognized in the same period of 2020.

      Free Cash Flow




      Three Months Ended


      (In thousands of U.S. Dollars)


      March 31, 2021


      Net cash used in operating activities


      $


      (10,951)


      Net cash provided by investing activities




      14,256


      Free cash flow


      $


      3,305


      SOURCE IMAX Corporation

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.